$450.00
| Product Name | Humatrope |
| Dosage | 5 mg (15 IU) |
| Origin | rDNA |
| Form | Injectable |
| Packaging | Combination package |
| Usage | Physician-prescribed injection for growth hormone deficiency. |
| Storage | Refrigerated |
| Features | Tissue repair, Cell regeneration, Immune support, Muscle growth, Fat loss |
Somatropin (recombinant human growth hormone, rhGH) is a synthetic version of the hormone naturally produced by the pituitary gland. Humatrope Vial 5 mg is a somatropin-based therapy manufactured by Eli Lilly and Company, used in regulated clinical settings to treat growth hormone deficiencies and related conditions. It is a prescription-only medication requiring qualified medical supervision.
Recombinant human growth hormone plays a vital role in:
When natural growth hormone production is insufficient, somatropin therapy may be prescribed to restore normal physiological balance.
Somatropin therapies such as Humatrope Vial 5 mg may be prescribed for:
Use is based on confirmed diagnosis and specialist evaluation.
Somatropin mimics the body’s natural growth hormone by:
These actions contribute to improved growth outcomes and overall physiological health.
Patients should follow healthcare provider instructions carefully.
Seek medical attention for severe or persistent symptoms.
Somatropin products, including Humatrope Vial 5 mg, are regulated prescription medications in many countries. Unauthorized use or distribution may be illegal.

















